OMEPRAZOLE TOWA PHARMACEUTICAL EUROPE 20 mg, gastro-resistant capsule 28 capsules
Active ingredients: Omeprazole
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant capsule28 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OMEPRAZOLE TOWA PHARMACEUTICAL EUROPE 20 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 28 gélule(s)
- Marketing authorisation holder
- TOWA PHARMACEUTICAL EUROPE (ESPAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Dec 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67928853CIP72796606CIP133400927966064Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OMÉPRAZOLEgélule | 20 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.